Skip to content

RadNet, Inc.

RDNT · XNAS

CIK 790526fmd_0JWTMHRS0HMN72AEMGDHPB8XX4Services · Services-Medical LaboratoriesTemplate: Standard

Coverage: Jan 01, 2009 to Sep 30, 2026, 67 periods

Income Statement · Annual · Millions · USD
Line itemFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Total revenues8859229751,1541,0721,3151,4301,6171,8302,040
Cost of revenue7768028681,000––––––
Gross profit109120108154––––––
Asset management and advisory fees1213––––––––
Total operating expenses8468729441,0841,0621,2421,3841,5181,7251,978
Operating income385031703683469910562
Interest expense43414348464951648070
Interest and investment income––––––––3132
Other non-operating income (expense)(26)(24)8(40)(37)(24)(3)(60)(60)(30)
Income before taxes12263930(1)5943394532
Income tax expense4240611598615
Net income from continuing operations823823(2)4434303917
Net income703215(15)251133(19)
Net income to common shareholders––––(15)251033(19)